UCB Biopharma SPRL operates as a pharmaceutical company. The Company manufactures and supplies a wide range of medicines and drugs for neurology and immunology. UCB Biopharma serves customers worldwide.
In India, the business of UCB Biopharma SPRL focuses on MULTI-SPECIFIC ANTIBODY MOLECULES HAVING SPECIFICITY FOR TNF-ALPHA, IL-17A, and IL-17F, Specific trifluoromethyl quinoline analog for use in the treatment of Sjögren’s syndrome, Anti-FcRn Antibodies, and Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity.
UCB Biopharma SPRL filed a patent application numbered 201617022163 that is titled FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY. The patent has been filed in the field of Chemicals. This Patent Application has been granted as Patent Number 352239. This invention relates to a compound represented by formula (I) or an N-oxide thereof, IIA), or a pharmaceutically acceptable salt or solvate thereof, or a glucuronide derivative thereof, or a co-crystal thereof.
During the patent examination, the Patent Examiner raised objections under Section 3(d) of the Patents (Amended) Act, 2005 stating that the Claims are a mere derivative of already known compounds. Unless the present compounds differ with regard to efficacy, certain claims are not allowable.
As a response, the Applicant submitted that the claims are directed to compounds which are both novel and inventive. Thus, the claims do not define a “known substance” and the provisions of Section 3(d) do not apply.
Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter.
Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech).
Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.
